Prevalence of Estrogen Receptor Alpha (ESR1) Somatic Mutations in Breast Cancer

Estrogen receptor–positive breast tumors, which initially respond effectively to endocrine therapy, progress due to acquired endocrine therapy resistance, including genomic alterations in estrogen receptor alpha (ESR1). A recent study has suggested that there is a sufficient number of preexisting ES...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinslow, Connor J, Tang, Ashley, Chaudhary, Kunal R, Cheng, Simon K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438742/
https://www.ncbi.nlm.nih.gov/pubmed/35959983
http://dx.doi.org/10.1093/jncics/pkac060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438742/
https://www.ncbi.nlm.nih.gov/pubmed/35959983
http://dx.doi.org/10.1093/jncics/pkac060

Ejemplares similares